HONG KONG, CHINA - Media OutReach - July 03, 2019 - The first day of the 2019 Global Biotechnology Weekwas co-sponsored by the Hong Kong Stock Exchange, the China Great Bay AreaDistrict Common Residential Investment Co., Ltd. and Ausvic Capital (Hong Kong)Co., Ltd. The Nobel and Turing Award winners Hong Kong Summit officiallylaunched this afternoon. Leaders from the global biotechnology communitygathered in the Hong Kong Financial Hall, including biotech-related NobelPrize, Turing Award, Fields Prize winner. Chen Maobo, Financial Secretary of theHong Kong Special Administrative Region Government, Li Xiaojia, Chief ExecutiveOfficer of the Hong Kong Stock Exchange Group, Chairman of the Board ofDirectors of Dawan District Common Home Investment Co., Ltd. and Chairman ofChina Resources Group, Dr. Fu Yuning, and Founding Partner of Ausvic Capital,Chen Pingjun Participated in the event and delivered a wonderful speech at thesummit.
Li Xiaojia believed that in the field ofbiotechnology, no matter which country he or she comes from, there is only onecommon enemy of "disease".
Mr. Chen Maobo pointed out that Hong Konghas an advantage in biotechnology and would work hard to promote biotechnology.
Dr. Fu Yuying said that Hong Kong shouldattract and promote exchanges and exchanges between experts and investors inthe field of biotechnology, and jointly promote scientific and technologicalprogress for the benefit of mankind and the world.
Nobel Laureate Professor Aaron Ciechanovergave a keynote speech on personalized medicine. He believed that the futurewould be an era of precision medicine. Based on personalized medicine andcombined with genome sequencing technology, proteomics technology would developmore "appropriate" prevention, diagnosis and treatment options for the humanbody. The Turing Award Winner Professor Joseph Sifakis elaborated on theopportunities and threats in the knowledge revolution. He said that the role ofartificial intelligence depended mainly on human choice. The long-term approachto challenging artificial intelligence was to build the next generation ofautonomous systems.
In addition, Chen Ping, founding partner ofAusvic Capital, one of the organizers of the first day of the summit, delivereda wonderful speech at the summit. He said that Ausvic Capital attached greatimportance to the academic research and application of science and technology.In the future, Ausvic will focus on investing in biotechnology in combinationwith its own high-quality resources to promote the development of cutting-edgebiotechnology for the benefit of mankind. At the same time, work intensivelywith world award winners and work closely with individual world-class funds;
Chen Ping believed that with the global economic slowdown, thepurchasing rate will decline in the next 10 years, and only a new generation oftechnology will have an opportunity. Hong Kong should seize the opportunity ofthis technological change. Therefore, I would like to make the followingrecommendations to the Hong Kong Government:
1.In Hong Kong Chinese Medicine Certification;
2.Focus on the introduction of world-class scientific andtechnological talents and build a world-class technology port. Theestablishment of a world-class authority for new drug approval departments willmake Hong Kong a standardizer for biotechnology and will affect the future ofHong Kong.
At the third round table, scientists had awonderful discussion on "the future of biotechnology." The roundtable was chaired by Professor Harvey Lodish, a professor at the MassachusettsInstitute of Technology and a member of the National Academy of Sciences. Thewinners of the round table include:
Professor Aaron Ciechanover, winner of the2004 Nobel Prize in Chemistry
Professor Ada E.Yonath, winner of the 2009Nobel Prize in Chemistry
Professor Joseph Sifakis, winner of the2007 Turing Awards
Professor Caucher Birkar, winner of the2018 Fields Prize
Everyone is talking about the future ofbiotechnology, which benefits participants and everyone is thunderous.
As one of the four clear new economic driversof the Hong Kong government, the success of the summit will accelerate thedevelopment of Hong Kong's biotechnology industry and further improve theinvestment and financing environment of biotechnology in Hong Kong. At the sametime, it will help investors to understand the cutting-edge technologies andindustrial development policies of biomedical innovation and promote thehealthy development of human beings.
About Ausvic Capital
Ausvic Capital was founded in 2018. It is a leading technology investment management agency initiated by a group of professionals with equity investment background. The main founders have extensive experience in high-tech venture capital and corporate management. The fund's main investment areas are biotechnology, digital economy and artificial intelligence + cloud services. While providing funds for entrepreneurs, it provides talents and technical guidance for the stable and rapid development of enterprises, and grafts various resources for investment enterprises to promote the rapid and healthy development of investment enterprises.